175 related articles for article (PubMed ID: 2601830)
21. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
[No Abstract] [Full Text] [Related]
22. Case report: psychosis with Stevens-Johnson syndrome and toxic epidermal necrolysis.
de Rego JA; Goldstein DM
Hillside J Clin Psychiatry; 1985; 7(2):141-8. PubMed ID: 4077031
[TBL] [Abstract][Full Text] [Related]
23. Management of drug-induced toxic epidermal necrolysis.
Eisen ER; Fish J; Shear NH
J Cutan Med Surg; 2000 Apr; 4(2):96-102. PubMed ID: 11179933
[No Abstract] [Full Text] [Related]
24. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
25. Toxic epidermal necrolysis due to antiepileptic therapy in an 8-year-old boy.
Muhar U; Granditsch G; Diem E
Pediatr Dermatol; 1985 Nov; 3(1):54-8. PubMed ID: 4070087
[TBL] [Abstract][Full Text] [Related]
26. The association of HLA B*15:02 allele and Stevens-Johnson syndrome/toxic epidermal necrolysis induced by aromatic anticonvulsant drugs in a South Indian population.
Devi K
Int J Dermatol; 2018 Jan; 57(1):70-73. PubMed ID: 29076187
[TBL] [Abstract][Full Text] [Related]
27. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
28. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides].
Aberer W; Stingl G; Wolff K
Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants associated with phenytoin-related severe cutaneous adverse reactions.
Chung WH; Chang WC; Lee YS; Wu YY; Yang CH; Ho HC; Chen MJ; Lin JY; Hui RC; Ho JC; Wu WM; Chen TJ; Wu T; Wu YR; Hsih MS; Tu PH; Chang CN; Hsu CN; Wu TL; Choon SE; Hsu CK; Chen DY; Liu CS; Lin CY; Kaniwa N; Saito Y; Takahashi Y; Nakamura R; Azukizawa H; Shi Y; Wang TH; Chuang SS; Tsai SF; Chang CJ; Chang YS; Hung SI; ;
JAMA; 2014 Aug; 312(5):525-34. PubMed ID: 25096692
[TBL] [Abstract][Full Text] [Related]
30. Toxic epidermal necrolysis of the scalp following anticonvulsant use and cranial irradiation.
Trent JT; Bowes LE; Romanelli P; Kerdel FA
J Cutan Med Surg; 2001; 5(6):475-8. PubMed ID: 11907855
[TBL] [Abstract][Full Text] [Related]
31. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
[TBL] [Abstract][Full Text] [Related]
32. Stevens-Johnson syndrome and toxic epidermal necrolysis in a patient with systemic lupus erythematosus.
Burge SM; Dawber RP
J Am Acad Dermatol; 1985 Oct; 13(4):665-6. PubMed ID: 4078055
[No Abstract] [Full Text] [Related]
33. HLA-B∗ 1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population.
Aggarwal R; Sharma M; Modi M; Garg VK; Salaria M
Hum Immunol; 2014 Nov; 75(11):1120-2. PubMed ID: 25305458
[TBL] [Abstract][Full Text] [Related]
34. [Toxic epidermal necrolysis after treatment with lamotrigine].
Zachariae CO; Fogh K
Ugeskr Laeger; 1998 Nov; 160(46):6656-7. PubMed ID: 9825684
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
Ririe MR; Blaylock RC; Morris SE; Jung JY
J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
[TBL] [Abstract][Full Text] [Related]
36. Toxic epidermal necrolysis.
Lacy JA
Nutr Clin Pract; 1991 Feb; 6(1):18-20. PubMed ID: 1775102
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis.
Stern RS; Chan HL
J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):317-22. PubMed ID: 2671067
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
39. Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy.
Fallon MJ; Heck JN
J Oncol Pharm Pract; 2015 Oct; 21(5):388-92. PubMed ID: 25005569
[TBL] [Abstract][Full Text] [Related]
40. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
